1. Twenty-four-hour serum creatinine variation is associated with poor outcome in the novel coronavirus disease 2019 (COVID-19) patients
- Author
-
Gaetano Alfano, Annachiara Ferrari, Francesco Fontana, Giacomo Mori, Giulia Ligabue, Silvia Giovanella, Riccardo Magistroni, Marianna Meschiari, Erica Franceschini, Marianna Menozzi, Gianluca Cuomo, Gabriella Orlando, Antonella Santoro, Margherita Di Gaetano, Cinzia Puzzolante, Federica Carli, Andrea Bedini, Jovana Milic, Cristina Mussini, Gianni Cappelli, and Giovanni Guaraldi
- Subjects
acute kidney injury ,biomarkers ,coronavirus ,kidney ,creatinine ,mortality ,Internal medicine ,RC31-1245 ,Specialties of internal medicine ,RC581-951 - Abstract
Background The prognostic value of within-day sCr variation serum creatinine variation is unknown in the setting of the novel coronavirus disease 2019 (COVID-19). We evaluated the prognostic significance of 24-hour serum creatinine variation in COVID-19 patients. Methods A monocentric retrospective analysis was conducted in COVID-19 patients not admitted to the intensive care unit. Three groups were subdivided based on 24 hours serum creatinine variation from admission. In the stable kidney function group, 24-hour serum creatinine variation ranged from +0.05 to –0.05 mg/dL; in the decreased kidney function group, 24-hour serum creatinine variation was >0.05 mg/dL; in the improved kidney function group, 24-hour serum creatinine variation was
- Published
- 2021
- Full Text
- View/download PDF